首页> 外文会议>NanoInnovation -Conference and Exhibition >Solid Lipid Nanoparticles Made of Self-Emulsifying Lipids for Efficient Encapsulation of Hydrophilic Substances
【24h】

Solid Lipid Nanoparticles Made of Self-Emulsifying Lipids for Efficient Encapsulation of Hydrophilic Substances

机译:由自乳化脂质制成的固体脂质纳米颗粒,用于有效封装亲水性物质

获取原文

摘要

In the last decades, most attention has been paid to solid lipid nanoparticles (SLN) as nanocarriers for pharmaceutical purposes due to their low toxicity, possible production on large scale and delivery of active principles by several administration routes. For example, lung delivery will necessitate direct administration, e.g. by aerosolisation, to maximize deposition into the airways and minimize systemic side effects. However, SLN based on common solid lipids preferentially incorporate lipophilic drugs, while the hydrophilic ones are loaded in low amount. To overcome this drawback, it seemed interesting to evaluate SLN based on self-emulsifying (SE) lipids, which are mixtures of lipids, surfactant and cosurfactants able to form emulsions in contact with aqueous media. Thus, we evaluated the preparation of SLN based on Gelucire~? 50/13, selected as a SE lipid model, encapsulating glutathione (GSH) or proanthocyanidins occurring in grape seed extract (GSE), as hydrophilic model substances according to the melt-emulsification method. The encapsulation efficiency of such GSH- or GSE-SLN resulted satisfactory for both the hydrophilic compounds examined. However, to draw definitive conclusions on the scope and limitations of this approach based on SE lipids, further studies are necessary. Moreover, GSH-SLN were investigated for their performance in delivering the antioxidant peptide to immunocompetent fish cells, while GSE-SLN were evaluated for their possible application in the treatment of pulmonary diseases. It was found that GSH-SLN were not internalized by fish cells, while GSE-SLN showed favorable properties for lung delivery.
机译:在过去的几十年中,由于其低毒性,最多的脂质纳米颗粒(SLN)作为药物目的的纳米载体,可能产生大规模的生产,并通过几种给药路线提供活跃原理的纳米载体。例如,肺递送将需要直接给药,例如,通过雾化,最大限度地沉积到气道中,并最大限度地减少系统副作用。然而,基于常见的固体脂质的SLN优先掺入亲脂性药物,而亲水性被加入低量。为了克服该缺点,似乎有趣的是评估基于自乳化(SE)脂质的SLN,它们是能够形成与含水介质接触的乳液的脂质,表面活性剂和含有粘合剂的混合物。因此,我们评估了基于Gelucire的SLN的制备〜? 50/13,选择作为SE脂质模型,包封在葡萄种子提取物(GSE)中发生的谷胱甘肽(GSH)或花青蛋白,作为根据熔融乳化方法的亲水性模型物质。这种GSH或GSE-SLN的封装效率导致了所检查的亲水化合物的令人满意。然而,为了基于SE脂质的这种方法的范围和局限性得出明确的结论,需要进一步研究。此外,研究了GSH-SLN的性能在将抗氧化肽递送到免疫紊乱的鱼类细胞,而GSE-SLN被评估在治疗肺部疾病中的可能应用。发现GSH-SLN未被鱼类细胞内化,而GSE-SLN显示出肺部递送的有利性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号